How many applications does it take to get a pharma job interview, and does sending more of them help?
Recruiting-platform data across more than ten million applications puts the applicant-to-interview rate at roughly 3%, with around 180 applicants per hire, and applications per role have roughly tripled since 2021. That 3% is a pooled average, dragged down by people who spray applications at roles they were never going to get. Sending more does not help. Filtering does. Read the advert for its must-haves, the hard bars such as GMP experience, a regulatory-affairs track record or a C1 language level, apply when you clear them credibly at maybe 70% of the full list, and walk past everything else.
Dear MoreThanCareer.de community,
Save this one. I am not precious about it. I say it because there will come an evening, application number 47, 22:40, third coffee, when you will need someone to talk you down, and I would rather it were a saved article than the “Easy Apply” button. Everything I actually do about this problem sits inside my career coaching programmes: job-search strategy, interview preparation and salary-negotiation training with scripts written for your case, plus reverse recruitment and CV and LinkedIn rewrites. There. Housekeeping done.
The most flattering lie in the modern job search
Let us begin with the most flattering lie in the modern job search, flattering precisely because it never once feels like a lie: sending applications is progress. You open forty tabs. You upload the same weary PDF forty times. You hit submit, and your nervous system, bless it, hands you a little dopamine biscuit for having Done Something Productive. This is Beschäftigungstherapie (occupational therapy, the sort of busywork designed to make you feel useful rather than to accomplish anything). It is the career equivalent of Operation gelungen, Patient tot (operation a success, patient dead): all the vital signs of effort, none of the outcome. Viel hilft viel (a lot helps a lot) is a marvellous philosophy for gym sets and, at a push, Riesling. In pharmacology it is how you achieve toxicity. In a job search it is how you achieve 180 rejections and a standing order with your local barista.
The number that spoils the party
Recruiting-platform data across more than ten million applications puts the applicant-to-interview rate at roughly 3%, with the average opening drawing around 180 applicants per hire.1 Applications per role have roughly tripled since 2021,2 a triumph made possible by one-click “Easy Apply” buttons, which were engineered, and I cannot stress this enough, to make applying so frictionless that you would do it without thinking.3 Mission accomplished, everyone.
Now, everybody reads that 3% and quietly assumes it is a verdict on them. It is not. It is the pooled average of an enormous crowd, and that crowd is overwhelmingly composed of people applying to roles they were never going to get. The same dataset shows job-board sprayers convert far worse than people who actually researched the role first.1 The 3% is being dragged into the cellar by the confetti-cannon brigade, the people mit Kanonen auf Spatzen schießen (shooting at sparrows with cannons, spectacular overkill, nothing to show for it). Which is the good news, if you will let it be: the instant you stop being the confetti cannon, your personal odds unhook from the average and start climbing. That is the entire mechanism behind sending fewer applications and getting more interviews. It is not a hack. It is long division. (The “50%” some of you saw in another headline is the shape of the mechanism, not a notarised guarantee. How much you gain depends entirely on how enthusiastically you were carpet-bombing to start with.)
“But men apply at 60% and women at 100%, so surely I should just apply to everything?”
Ah yes. The most-cited statistic in the history of career advice, wheeled out to mean stop overthinking, hit apply, confidence conquers all. Two small problems, both fatal.
First, trace it. The figure comes from an unpublished Hewlett-Packard internal report, never peer-reviewed, and, by the available accounts, about candidates for internal promotion rather than people cold-applying to jobs.4 It has been laundered through a decade of “lean in” listicles until everyone treats it as gospel handed down on a stone tablet. Second, when Tara Sophia Mohr actually surveyed people for Harvard Business Review, the top reason both sexes gave for not applying had nothing to do with a confidence deficit. It was that they read the listed qualifications as, astonishingly, required qualifications.4 The error was never nerve. It was misreading the process. So the confidence-industrial complex spent ten years selling a cure for the wrong disease. Chapeau.
Must-haves, nice-to-haves and the 70% that decides it
Here is the reflective version, worth more than either “apply to everything” or “only apply at 100%”. A job ad has two layers. There are must-haves, the hard bars: the GMP experience, the regulatory-affairs track record, the C1 German, the actual degree that HR will actually check. And there are nice-to-haves, the wishlist bolted on because someone in the meeting said “let us aim high”. Papier ist geduldig (paper is patient); an ad will cheerfully list twelve requirements for a role that honestly needs six. The quality strategy is neither to ignore the requirements nor to prostrate yourself before all twelve. It is to clear the must-haves credibly, even at maybe 70% of the total list, and to walk past the roles where you miss a hard bar. Spraying and self-eliminating are the identical mistake in different outfits: neither is judging fit. Klasse statt Masse (class over mass), yes, I am aware it is printed on motivational mugs. The mug is wrong about nearly everything. It is right about this. If you want the method rather than the slogan, that is precisely what a proper pharma job-search strategy is for.
A brief word on the robots you keep blaming
Roughly half of you are winding up to tell me the ATS ate your CV, because “75% of CVs are auto-rejected by applicant tracking systems” is treated as settled science. It is not science. It is marketing. Investigators have traced the figure to a defunct 2013 startup’s sales pitch, and searches of the academic literature return precisely nothing to support it.5 The robots are a wonderfully comforting villain, impersonal, faceless, definitely-not-your-fault, and yet formatting matters far less than you have been told. What actually sinks applications is content that does not match the must-haves. Which is, how convenient, the exact thing a quality strategy fixes and a two-column-versus-one-column existential crisis does not. The sober version of what these systems do and do not do is in my piece on how to beat the ATS in pharma.
The DACH twist, and why this hurts less here than in Manhattan
There is a structural reason this approach suits the DACH market beautifully. German-speaking hiring still largely expects a tailored Anschreiben (cover letter): the Bundesagentur für Arbeit treats it as one of the most influential documents in the Bewerbung, and a meaningful slice of HR still bins applications that arrive without one.6 Tailoring here is no charming extra. It is the toll on the bridge. Compare the Anglo-American “one-click and pray” default, which mass-manufactures the very volume that then crushes everyone’s conversion rate. In fairness, DACH is not monolithic. Deutsche Bahn scrapped the mandatory cover letter in 2019, Otto back in 2016,6 so read each employer rather than the folklore. The underlying point holds across borders. In the US and the UK, quality is how you escape the volume casino. In DACH, quality was always the house rule, and a distressing number of people simply stopped following it. In high-volume markets like China and India the maths is identical, only louder and with more zeros.
Five things that actually work
- Build a must-have filter before you type a single word. For each role, list its hard bars and honestly tick them off. Miss one non-negotiable, the licence, the therapeutic area, the language level, and it is a no, however seductive the logo. Highest-return habit I teach, and it costs nothing but the ego bruise of admitting a role is not for you.
- Score the role, then decide. A one-minute fit check (must-haves met, seniority match, is this opening even real) beats the gut feeling whispering “maybe they will see something in me”. They will not. They have 179 other people in whom to also not see something.
- Tailor to the must-haves, not to a keyword casserole. Mirror the role’s real requirements with evidence, not adjectives. This is where fewer-and-better earns its rent: you finally have the hours to do it properly.
- Cap the volume, raise the bar. Set a weekly ceiling on applications and pour the reclaimed evenings into research and relationships. Referred and sourced candidates convert at multiples of cold applicants,1 and that is where your effort belongs the moment the carpet-bombing stops. I took that market apart in the hidden job market and the referral economy.
- Track your own conversion rate, not the internet’s. If your applications-per-interview ratio is grim, the culprit is almost always target selection rather than effort. The market’s averages describe the herd. The entire plan is to stop being the herd.
What changes by career stage
Juniors chasing internships, traineeships or entry roles have softer must-haves, so fit is mostly demonstrated interest and a credible reason you chose this team over the 300 others. If you need visa sponsorship, filter for sponsor-willing employers first, rather than pouring your Hoffnung into the ones who were never going to say yes (die Hoffnung stirbt zuletzt, hope dies last, but it really ought not die on an application form that says “no sponsorship available”).
Mid-career and senior professionals: fewer roles honestly fit you as you specialise, which makes quality the only sane setting rather than a luxury upgrade. Executives and C-level: your relevant market is small and gossipy, so forty precise, well-routed conversations beat two hundred portal submissions that broadcast your availability to your entire industry, including your current employer. And to the 50+ readers who are told to “just apply to more”, please do not. Volume will not out-argue an age bias. A tightly targeted application that reframes your depth as institutional risk management will do more than a hundred hopeful ones ever could, which is the case I made in Part XI.
For the recruiters and hiring managers reading, you are not a bystander here
Every wishlist requirement you pad into an ad performs two miracles at once: it scares off capable stretch candidates and it stuffs your pile with hopefuls who ignored it entirely. Write honest must-haves. Separate them visibly from the nice-to-haves. Structured, transparent criteria raise applicant quality, cut your screening load, and, not a footnote, make the whole thing fairer and easier to defend when someone asks. The best talent is already running a quality strategy. The least you can do is write a job ad that does not punish them for it.
The system is not broken. It is noisy.
None of this is the customary “the system is broken and we shall all perish” homily. The system is not broken. It is noisy, vast volume and thin signal, and a quality strategy is simply the rational reply to noise. You do not get a vote on the 3%. You get a complete veto over which roles you dignify with your effort. That is more control than the doom merchants will ever admit you have.
Your turn
Four questions worth answering honestly, on paper, this week.
- What is your current applications-per-interview ratio, and, hand on heart, are you even tracking it, or just vibing?
- Which single missing must-have has quietly cost you the most interviews? (Naming it is half the cure.)
- Recruiters: what is the most gloriously pointless “requirement” you have watched get padded into a pharma job ad this year?
- 50+ readers: has going narrower and sharper worked, or did volume just feel safer while achieving nothing?
The full quality-application method is also the spine of my forthcoming book, Surviving the Pharma Bloodbath: The Ultimate Job Search Guide for Pharma in DACH & US (working title).
Prost. Und passt auf euch auf. (Cheers. And look after yourselves.)
Sources & References
A note on the numbers: the recruitment benchmarks below come largely from recruiting-platform and vendor datasets rather than government censuses, so treat them as directional rather than gospel. Where a widely-quoted figure has no real study behind it, I have said so plainly. Credible or primary sources and vendor or industry sources are separated.
Credible / primary:
[4] Mohr, T. S., “Why Women Don’t Apply for Jobs Unless They’re 100% Qualified”, Harvard Business Review (2014). Origin of the 60%/100% figure (unpublished HP internal report, not peer-reviewed) and the survey on why people actually do not apply: hbr.org
[6] Bundesagentur für Arbeit guidance treating the Anschreiben as a central element of the German Bewerbung (as reflected in current application guidance); counter-trend examples, Deutsche Bahn (2019) and Otto (2016) dropped mandatory cover letters, overview at settle-in-berlin.com
Vendor / industry benchmark (directional):
[1] CareerPlug, 2025 Recruiting Metrics Report (10M+ applications): ~3% applicant-to-interview, ~27% interview-to-hire, ~180 applicants per hire; job-board applicants convert worse than researched or referred applicants: careerplug.com
[2] Ashby, 2025 Talent Trends Report: applications per hire have roughly tripled since 2021 (as reported): pin.com
[3] Appcast, 2025 Recruitment Marketing Benchmark Report: ~6.1% click-to-apply; one-click and mobile apply lifted apply rates (a ~35% increase noted in 2024): pin.com
[5] On the “75% of CVs rejected by ATS” claim: traced to a defunct 2013 startup with no supporting study; an investigation cited by Ask a Manager, HiringThing and HR.com found no academic basis for it: resumeadapter.com
© 7 July 2026 Andreas Schulz. All rights reserved.
Ready to take control of your pharma career?
Book a free getting-to-know call. I will tell you honestly where you stand, what the DACH pharma market looks like for your profile, and what your next move should be.
Book a Free Getting-to-Know Call